SEC Form 4 · accession 0001209191-15-071455

KYNTRA BIO, INC. · KYNB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director · 10% Owner

Period of report

Sep 17, 2015

Accepted (ET)

Sep 18, 2015 · 5:50 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000921299

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Sep 17, 2015	S	6,700	$28.80	D	3,856,051	D
Common Stock^F1,F3	Sep 17, 2015	S	6,800	$29.27	D	3,849,251	D
Common Stock	Sep 17, 2015	M	1,391	$2.35	A	3,850,642	D
Common Stock	Sep 17, 2015	M	8,078	$2.90	A	3,858,720	D
Common Stock^F1,F4	Sep 18, 2015	S	2,000	$28.89	D	3,856,720	D
Common Stock^F1,F5	Sep 18, 2015	S	11,500	$29.21	D	3,845,220	D
Common Stock	Sep 18, 2015	M	9,469	$2.90	A	3,854,689	D
Common Stock	holding	—	—		—	145,070	I	By Family Partnership
Common Stock	holding	—	—		—	20,000	I	By Spouse
Common Stock^F6	holding	—	—		—	60,946	I	See footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F7	$2.35	Sep 17, 2015	M	1,391	D	—	Mar 12, 2018	Common Stock	1,391	303,919	D
Stock Option (Right to Buy)^F7	$2.90	Sep 17, 2015	M	8,078	D	—	Jun 9, 2020	Common Stock	8,078	387,922	D
Stock Option (Right to Buy)^F7	$2.90	Sep 18, 2015	M	9,469	D	—	Jun 9, 2020	Common Stock	9,469	378,453	D

F1Shares sold pursuant to a 10b5-1 plan.
F2The shares were sold at prices ranging from $28.12 to $29.11. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3The shares were sold at prices ranging from $29.12 to $29.55. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4The shares were sold at prices ranging from $28.75 to $28.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F5The shares were sold at prices ranging from $29.01 to $29.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
F6The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
F7Fully vested.